Tender

SBRI Challenge - Accelerating the diagnosis, management and support of people diagnosed with cancer in Wales and Northern Ireland

  • NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)

F02: Contract notice

Notice identifier: 2024/S 000-027421

Procurement identifier (OCID): ocds-h6vhtk-0495f7

Published 28 August 2024, 12:30pm



Section one: Contracting authority

one.1) Name and addresses

NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)

SBRI Centre of Excellence,IMT Building,Wrexham Maelor Hospital

Wrexham

LL13 7TD

Email

casey.chapman@wales.nhs.uk

Country

United Kingdom

NUTS code

UKL - Wales

Internet address(es)

Main address

https://sdi.click/sbricancerchallenge

Buyer's address

https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221

one.2) Information about joint procurement

The contract is awarded by a central purchasing body

one.3) Communication

The procurement documents are available for unrestricted and full direct access, free of charge, at

https://sdi.click/sbricancerchallenge

Additional information can be obtained from the above-mentioned address

Tenders or requests to participate must be submitted electronically via

https://sdi.click/sbricancerchallenge

Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at

https://sdi.click/sbricancerchallenge

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

SBRI Challenge - Accelerating the diagnosis, management and support of people diagnosed with cancer in Wales and Northern Ireland

two.1.2) Main CPV code

  • 85100000 - Health services

two.1.3) Type of contract

Services

two.1.4) Short description

This exciting first of its kind Cancer Challenge is a collaboration between the SBRI Centre of Excellence in Wales and the Innovation and Market Development Unit in Northern Ireland. The challenge seeks innovations that lead to earlier, faster diagnosis, reduction in waiting times, improvements to the efficiency and efficacy of treatment and support palliative care.

Further information: https://sdi.click/sbricancerchallenge

two.1.5) Estimated total value

Value excluding VAT: £1,000,000

two.1.6) Information about lots

This contract is divided into lots: No

two.2) Description

two.2.2) Additional CPV code(s)

  • 85000000 - Health and social work services
  • 85100000 - Health services
  • 85140000 - Miscellaneous health services
  • 33150000 - Radiotherapy, mechanotherapy, electrotherapy and physical therapy devices

two.2.3) Place of performance

NUTS codes
  • UKL - Wales
  • UKN - Northern Ireland

two.2.4) Description of the procurement

This exciting first of its kind Cancer Challenge is a collaboration between the SBRI Centre of Excellence in Wales and the Innovation and Market Development Unit in Northern Ireland. The challenge seeks innovations that lead to earlier, faster diagnosis, reduction in waiting times, improvements to the efficiency and efficacy of treatment and support palliative care.

Challenge Theme

Typically, SBRI challenges commence with a Phase 1 Feasibility stage. However, for this challenge we are looking for real-world trials and therefore will not be supporting Phase 1 or 2 projects. We are seeking to identify and support the delivery of Phase 3 collaborative projects that can demonstrate the potential and scalability of emerging and near-to-market solutions.

Successful outcomes should demonstrate measurable improvements in cancer patient outcomes, reduce health inequalities and provide advancements in efficacy/efficiency in one or more of the following key areas:

- Cancer screening/earlier diagnosis

- Faster diagnosis

- Reduced waiting times

- Cancer treatments including Surgery, Radiotherapy and Systemic Therapy

- Acute Oncology Services

- Specialist Cancer Services

- Palliative Care

The key focus will be on real-world trials of emerging and near-to-market innovations within Northern Ireland and/or Wales which will demonstrate efficacy, sustainability of service, affordability and scalability of solutions that can be delivered at pace where financial viability will be key. We are not seeking research projects such as early feasibility studies or evidence generation studies aimed at developing the product/solution further.

However, we are seeking rigorous evaluations and adoption readiness reports that support the required evidence base for service development and potential scale-up across Wales and Northern Ireland, which may also be valid in other health care contexts.

If project applications are seeking to build upon previous real word trials/small-scale testing, applications must clearly articulate the next phase and how this funding will help accelerate this work, outlining any previous adoption barriers and demonstrating how these will be addressed.

- Applications are invited to include a named health, public or third sector collaborator within Wales or Northern Ireland who has committed to their involvement in the project, evidenced by a signed letter of support. However, innovations will be evaluated on merit, and we will endeavour to facilitate partnerships for those who do not have any existing relationships;

- Funding for collaborator costs should be included as a subcontractor cost in the project applications;

- Projects can include more than one subcontractor; however, the involvement and role of each organisation should be clearly specified and the commitment evidenced, ideally with named individuals stated in the application;

- Multi-sector applications will be welcomed – in particular, applications that demonstrate significant benefits for NHS & Third Sector organisations;

- Academic partners are also welcomed, particularly in relation to independent evaluation and meeting any required technical/scientific testing.

Prior to the award of contract, successful applications will be required to evidence that they have obtained relevant certification/approvals and are suitably positioned to proceed upon project commencement

The challenge has been posted on the 28th of August 2024 with a closing date of the 27th of September 2024. For furhter informaiton or to submit a bid: https://sdi.click/sbricancerchallenge

two.2.5) Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

two.2.6) Estimated value

Value excluding VAT: £1,000,000

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

12

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: No

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No


Section three. Legal, economic, financial and technical information

three.1) Conditions for participation

three.1.2) Economic and financial standing

Selection criteria as stated in the procurement documents

three.1.3) Technical and professional ability

Selection criteria as stated in the procurement documents


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Open procedure

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

four.2) Administrative information

four.2.2) Time limit for receipt of tenders or requests to participate

Date

27 September 2024

Local time

12:00pm

four.2.4) Languages in which tenders or requests to participate may be submitted

English

four.2.6) Minimum time frame during which the tenderer must maintain the tender

Duration in months: 3 (from the date stated for receipt of tender)

four.2.7) Conditions for opening of tenders

Date

7 October 2024

Local time

12:00pm


Section six. Complementary information

six.1) Information about recurrence

This is a recurrent procurement: No

six.2) Information about electronic workflows

Electronic ordering will be used

Electronic invoicing will be accepted

Electronic payment will be used

six.3) Additional information

NOTE: To register your interest in this notice and obtain any additional information please visit the Sell2Wales Web Site at https://www.sell2wales.gov.wales/Search/Search_Switch.aspx?ID=144098.

(WA Ref:144098)

The buyer considers that this contract is suitable for consortia.

six.4) Procedures for review

six.4.1) Review body

High Court

Royal Courts of Justice, The Strand

London

WC2A 2LL

Telephone

+44 2079477501

Country

United Kingdom